Takeda's Takhzyro Shows Positive Results In Prevention Of HAE Attacks In Phase 3 Study In Children

Takeda's takhzyro or lanadelumab demonstrated positive results in the prevention of hereditary angioedema attacks in phase 3 SPRING study in children ages 2 to less than 12 years.

In this study, hereditary angioedema patients received a dose of 150 milligrams (mg) every 4 weeks in patients 2 to less than 6 years and every 2 weeks in patients aged 6 to less than 12 years.

According to the study results, Takhzyro reduced the rate of Hereditary Angioedema or HAE attacks in children by a mean of 94.8% over the 52-Week treatment period compared to baseline. The majority of patients (76.2%) were attack-free during the 52-week treatment period with an average of 99.5% attack-free days.

No deaths or serious treatment-emergent adverse events (TEAEs) were reported during the study, and no patients withdrew from the study due to TEAEs. The most commonly reported TEAE was injection site pain, and most TEAEs were mild or moderate in severity.

The results are consistent with the favorable efficacy and safety profile of takhzyro observed in earlier studies with adult and adolescent patients.

The global regulatory filings is expected to begin in fiscal year 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Seffner, Florida -based Canyon Furniture Co. is recalling ladders sold with bunk bed and hutch sets citing entrapment and strangulation risks, the U.S. Consumer Product Safety Commission said. The about 2,100 units of Canyon Lake and Cottage Colors Bunk Bed and Hutch Sets were sold exclusively at Rooms To Go. Lyft announced the expansion to its partnership with Indeed in Jobs Access program. The ride-hailing company will be providing transportation access for Indeed's Ready to Work program. Indeed's Ready to Work program is a series of free virtual and in-person events for job seekers in several cities across the U.S. from September 15 to October 8, 2022. Pool and Spa drain covers imported to the United States by various companies have been recalled due to violation of the Virginia Graeme Baker Pool and Spa Safety Act, the U.S. Consumer Product Safety Commission announced. The various recalls include pool and spa drain covers manufactured in China and sold exclusively at Amazon.com for different prices ranging from $10 to $12.
Follow RTT